Answers are grounded in this paper and cite their sources.
拉米夫定治疗慢性乙型肝炎(CHB)已积累了大量的临床数据,近期疗效良好,但是长期治疗易发生HBV变异和耐药[1].若能够在治疗的早期预测患者的远期疗效,将有利于对患者进行优化治疗.我们通过对拉米夫定治疗成人HBeAg阳性CHB患者的临床资料进行了分析,以期探索实际有用的疗效预测指标。
No takes yet. Share an insight, caveat, or question.
Liu et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: